• 30396 Citations
  • 87 Scopus h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1996 2019

Filter
Article
2019
6 Citations (Scopus)

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Dimopoulos, M. A., Grosicki, S., Jędrzejczak, W. W., Nahi, H., Gruber, A., Hansson, M., Gupta, N., Byrne, C., Labotka, R., Teng, Z., Yang, H., Grzasko, N. & Kumar, S. K., Jan 1 2019, In : European Journal of Cancer. 106, p. 89-98 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Cyclophosphamide
Dexamethasone
Transplants
Maintenance
3 Citations (Scopus)

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry–Verified Typing

Muchtar, E., Gertz, M., Kyle, R. A., Lacy, M., Dingli, D. M., Leung, N., Buadi, F. K., Hayman, S. R., Kapoor, P., Hwa, Y. L., Fonder, A., Hobbs, M., Gonsalves, W., Kourelis, T., Warsame, R., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S., Zeldenrust, S. & 3 others, Rajkumar, S. V., Kumar, S. K. & Dispenzieri, A., Mar 1 2019, In : Mayo Clinic proceedings. 94, 3, p. 472-483 12 p.

Research output: Contribution to journalArticle

Amyloidosis
Light
Kidney
Electrophoresis
Serum

Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function

Sidiqi, M. H., Nadiminti, K., Al Saleh, A. S., Meleveedu, K., Buadi, F. K., Dispenzieri, A., Warsame, R., Lacy, M., Dingli, D. M., Leung, N., Gonsalves, W., Kapoor, P., Kourelis, T., Hogan, W., Kumar, S. K. & Gertz, M., Jan 1 2019, In : Bone Marrow Transplantation.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Amyloidosis
Dialysis
Kidney
Melphalan
2 Citations (Scopus)

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis

Sidiqi, M. H., Buadi, F. K., Dispenzieri, A., Warsame, R., Lacy, M., Dingli, D. M., Leung, N., Gonsalves, W., Kapoor, P., Kourelis, T., Hogan, W., Kumar, S. K. & Gertz, M., Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Amyloidosis
Amyloid
Immunoglobulin M
Stem Cells
Transplants

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

Hsieh, R. W., Go, R. S., Abeykoon, J. P., Kapoor, P., Kumar, S. K., Gertz, M., Buadi, F. K., Leung, N., Gonsalves, W., Kourelis, T., Warsame, R. M., Dispenzieri, A., Lacy, M., Kyle, R. A., Rajkumar, S. V. & Paludo, J., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Multiple Myeloma
Survivors
Stem Cell Transplantation
Databases
Survival
2 Citations (Scopus)

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis

Sidana, S., Tandon, N., Gertz, M., Dispenzieri, A., Ramirez-Alvarado, M., Murray, D. L., Kourelis, T., Buadi, F. K., Kapoor, P., Gonsalves, W., Warsame, R., Lacy, M., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Leung, N., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalArticle

Amyloidosis
Kidney
Light
Plasma Cells
Bone Marrow Cells
4 Citations (Scopus)

Comparative analysis of staging systems in AL amyloidosis

Muchtar, E., Therneau, T. M., Larson, D. R., Gertz, M., Lacy, M., Buadi, F. K., Dingli, D. M., Hayman, S. R., Kapoor, P., Gonsalves, W., Kourelis, T., Warsame, R., Fonder, A., Hobbs, M., Hwa, Y. L., Leung, N., Russell, S. J., Lust, J. A., Lin, Y., Go, R. S. & 5 others, Zeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Dispenzieri, A., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Amyloidosis
Systems Analysis
2 Citations (Scopus)

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Aljama, M. A., Sidiqi, M. H., Dispenzieri, A., Gertz, M., Lacy, M., Buadi, F. K., Dingli, D. M., Muchtar, E., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W., Warsame, R. M., Kourelis, T., Hwa, Y. L., Kapoor, P., Leung, N., Go, R. S., Kyle, R. A., Rajkumar, S. V. & 1 others, Kumar, S. K., Jan 1 2019, In : Blood Advances. 3, 8, p. 1226-1229 4 p.

Research output: Contribution to journalArticle

Open Access
Immunoglobulin Light Chains
Brain Natriuretic Peptide
Amyloidosis
Biopsy
Amyloid

Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m 2 vs. twice-weekly 27 mg/m 2 carfilzomib (randomized A.R.R.O.W. study)

Moreau, P., Kumar, S. K., Boccia, R., Iida, S., Goldschmidt, H., Cocks, K., Trigg, A., Zahlten-Kumeli, A., Yucel, E., Panjabi, S. S. & Dimopoulos, M., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Open Access
Quality of Life
Multiple Myeloma
Odds Ratio
Random Allocation
Visual Analog Scale

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

Nandakumar, B., Kumar, S. K., Dispenzieri, A., Buadi, F. K., Dingli, D., Lacy, M. Q., Hayman, S. R., Kapoor, P., Leung, N., Fonder, A., Hobbs, M., Hwa, Y. L., Muchtar, E., Warsame, R., Kourelis, T. V., Russell, S., Lust, J. A., Lin, Y., Go, R. S., Siddiqui, M. & 5 others, Zeldenrust, S., Kyle, R. A., Gertz, M. A., Rajkumar, S. V. & Gonsalves, W. I., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Cytogenetics
Therapeutics
Survival
Plasma Cells
14 Citations (Scopus)

Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma

Facon, T., Kumar, S. K., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., Basu, S., Nahi, H., Hulin, C., Quach, H., Goldschmidt, H., O’Dwyer, M., Perrot, A., Venner, C. P., Weisel, K., Mace, J. R., Raje, N., Attal, M., Tiab, M., Macro, M. & 10 others, Frenzel, L., Leleu, X., Ahmadi, T., Chiu, C., Wang, J., Rampelbergh, R. V., Uhlar, C. M., Kobos, R., Qi, M. & Usmani, S. Z., May 30 2019, In : New England Journal of Medicine. 380, 22, p. 2104-2115 12 p.

Research output: Contribution to journalArticle

Dexamethasone
Disease Progression
Control Groups
Stem Cell Transplantation
Confidence Intervals

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

Mellors, P. W., Binder, M., Buadi, F. K., Lacy, M., Gertz, M., Dispenzieri, A., Hayman, S. R., Kapoor, P., Gonsalves, W., Hwa, Y. L., Fonder, A., Hobbs, M., Kourelis, T., Warsame, R., Zeldenrust, S. R., Lust, J. A., Leung, N., Go, R. S., Kyle, R. A., Rajkumar, S. V. & 1 others, Kumar, S. K., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Multiple Myeloma
Thrombocytopenia
Disease-Free Survival
Survival
Proteasome Inhibitors

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

Sidana, S., Sidiqi, M. H., Dispenzieri, A., Buadi, F. K., Lacy, M., Muchtar, E., Dingli, D. M., Hayman, S. R., Gonsalves, W., Kapoor, P., Leung, N., Warsame, R., Kourelis, T., Wolf, R. C., Hogan, W., Kumar, S. K. & Gertz, M., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Amyloidosis
Survival Rate
Transplants
Survival

Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients

Al Saleh, A. S., Sidiqi, M. H., Dispenzieri, A., Kapoor, P., Muchtar, E., Buadi, F. K., Warsame, R., Lacy, M. Q., Dingli, D., Leung, N., Gonsalves, W. I., Kourelis, T. V., Gertz, M. A., Go, R. S., Kyle, R. A., Rajkumar, S. V. & Kumar, S. K., Jan 1 2019, (Accepted/In press) In : American journal of hematology.

Research output: Contribution to journalArticle

Multiple Myeloma
Erythrocyte Indices
Survival
Hemoglobins
Blood Platelets
1 Citation (Scopus)

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma

Ramakrishnan, V. G., Miller, K. C., Macon, E. P., Kimlinger, T. K., Haug, J., Kumar, S., Gonsalves, W. I., Vincent Rajkumar, S. & Kumar, S. K., Jan 1 2019, In : Haematologica. 104, 10, p. 2061-2074 14 p.

Research output: Contribution to journalArticle

Open Access
Histone Deacetylases
Mitogen-Activated Protein Kinase Kinases
Multiple Myeloma
Histone Deacetylase Inhibitors
Cell Line
Waldenstrom Macroglobulinemia
Clinical Trials
Confidence Intervals
Disease-Free Survival
Immunoglobulin M

Impact of acquired del(17p) in multiple myeloma

Lakshman, A., Painuly, U., Vincent Rajkumar, S., Ketterling, R. P., Kapoor, P., Greipp, P. T., Dispenzieri, A., Gertz, M. A., Buadi, F. K., Lacy, M. Q., Dingli, D., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W. I., Hwa, Y. L., Leung, N., Go, R. S., Lin, Y., Kourelis, T. V. & 6 others, Warsame, R., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Kyle, R. A. & Kumar, S. K., Jan 1 2019, In : Blood Advances. 3, 13, p. 1930-1938 9 p.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Survival
Confidence Intervals
Odds Ratio
Plasma Cells

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

Al Saleh, A. S., Sidiqi, M. H., Sidana, S., Muchtar, E., Dispenzieri, A., Dingli, D. M., Lacy, M., Warsame, R. M., Gonsalves, W., Kourelis, T., Hogan, W., Hayman, S. R., Wolf, R. C., Kapoor, P., Buadi, F. K., Kumar, S. K. & Gertz, M., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Amyloidosis
Stem Cells
Transplants
Light
Therapeutics

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

Goyal, G., Rajkumar, S. V., Lacy, M., Gertz, M., Buadi, F. K., Dispenzieri, A., Hwa, Y. L., Fonder, A. L., Hobbs, M. A., Hayman, S. R., Zeldenrust, S. R., Lust, J. A., Russell, S. J., Leung, N., Kapoor, P., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Kyle, R. A. & 1 others, Kumar, S. K., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Monoclonal Gammopathy of Undetermined Significance
Paraproteinemias
Multiple Myeloma
Plasmacytoma
Survival
8 Citations (Scopus)

Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015

Kyle, R. A., Larson, D. R., Kurtin, P. J., Kumar, S. K., Cerhan, J. R., Therneau, T. M., Rajkumar, S. V., Vachon, C. M. & Dispenzieri, A., Jan 1 2019, (Accepted/In press) In : Mayo Clinic Proceedings.

Research output: Contribution to journalArticle

Amyloidosis
Incidence
Immunoglobulin Light Chains
Congo Red
Medical Records
1 Citation (Scopus)

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

Kumar, S. K., Berdeja, J. G., Niesvizky, R., Lonial, S., Laubach, J. P., Hamadani, M., Stewart, A. K., Hari, P., Roy, V., Vescio, R., Kaufman, J. L., Berg, D., Liao, E., Rajkumar, S. V. & Richardson, P. G., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Maintenance
Stem Cell Transplantation
Disease-Free Survival

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies

Dimopoulos, M. A., Laubach, J. P., Echeveste Gutierrez, M. A., Grzasko, N., Hofmeister, C. C., San-Miguel, J. F., Kumar, S. K., Labotka, R., Lu, V., Berg, D., Byrne, C., Teng, Z., Liu, G., van de Velde, H. & Richardson, P. G., Jun 1 2019, In : European Journal of Haematology. 102, 6, p. 494-503 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Maintenance
Dexamethasone
Melphalan
Therapeutics
Open Access
Tumor Microenvironment
T-Lymphocytes
Amyloidosis
Clonal Evolution
Tumor Escape
5 Citations (Scopus)

Molecular signatures of multiple myeloma progression through single cell RNA-Seq

Jang, J. S., Li, Y., Mitra, A. K., Bi, L., Abyzov, A., van Wijnen, A. J., Baughn, L., Van Ness, B., Rajkumar, S. V., Kumar, S. K. & Jen, J., Jan 1 2019, In : Blood Cancer Journal. 9, 1, 2.

Research output: Contribution to journalArticle

Multiple Myeloma
RNA
Genes
Oxidative Phosphorylation
Plasma Cells
1 Citation (Scopus)

Natural history of multiple myeloma with de novo del(17p)

Lakshman, A., Painuly, U., Rajkumar, S. V., Ketterling, R. P., Kapoor, P., Greipp, P. T., Gertz, M., Buadi, F. K., Lacy, M., Dingli, D. M., Dispenzieri, A., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W., Hwa, Y. L., Leung, N., Go, R. S., Lin, Y., Kourelis, T. & 6 others, Warsame, R., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Kyle, R. A. & Kumar, S. K., Mar 1 2019, In : Blood cancer journal. 9, 3, 32.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Survival
Disease-Free Survival
Proteasome Inhibitors
Group Psychotherapy

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020

Kumar, S. K., Callander, N. S., Hillengass, J., Liedtke, M., Baljevic, M., Campagnaro, E., Castillo, J. J., Chandler, J. C., Cornell, R. F., Costello, C., Efebera, Y., Faiman, M., Garfall, A., Godby, K., Holmberg, L., Htut, M., Huff, C. A., Kang, Y., Landgren, O., Malek, E. & 11 others, Martin, T., Omel, J., Raje, N., Sborov, D., Singhal, S., Stockerl-Goldstein, K., Tan, C., Weber, D., Johnson-Chilla, A., Keller, J. & Kumar, R., Oct 1 2019, In : Journal of the National Comprehensive Cancer Network : JNCCN. 17, 10, p. 1154-1165 12 p.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Guidelines
Aftercare
Paraproteinemias
Plasmacytoma
Stem Cell Transplantation
Amyloidosis
Light
Disease-Free Survival
Transplants
1 Citation (Scopus)

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy

Gandhi, U. H., Cornell, R. F., Lakshman, A., Gahvari, Z. J., McGehee, E., Jagosky, M. H., Gupta, R., Varnado, W., Fiala, M. A., Chhabra, S., Malek, E., Mansour, J., Paul, B., Barnstead, A., Kodali, S., Neppalli, A., Liedtke, M., Narayana, S., Godby, K. N., Kang, Y. & 9 others, Kansagra, A., Umyarova, E., Scott, E. C., Hari, P., Vij, R., Usmani, S. Z., Callander, N. S., Kumar, S. K. & Costa, L. J., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Monoclonal Antibodies
Therapeutics
Disease-Free Survival
Benchmarking
1 Citation (Scopus)

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

Tandon, N., Sidana, S., Rajkumar, S. V., Gertz, M., Buadi, F. K., Lacy, M., Kapoor, P., Gonsalves, W., Dispenzieri, A., Kourelis, T., Warsame, R., Dingli, D. M., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Hwa, Y. L., Kyle, R. A., Leung, N., Go, R. S., Lust, J. A. & 2 others, Russell, S. J. & Kumar, S. K., Mar 12 2019, In : Blood advances. 3, 5, p. 744-750 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Disease-Free Survival
Survival
Transplants
Cytogenetics
1 Citation (Scopus)

Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies

Kumar, S. K., Larson, D. R., Dispenzieri, A., Therneau, T. M., Murray, D. L., Bergsagel, P. L., Kyle, R. A. & Rajkumar, S. V., Jun 1 2019, In : Blood cancer journal. 9, 6, 49.

Research output: Contribution to journalArticle

Open Access
Paraproteinemias
Monoclonal Gammopathy of Undetermined Significance
Light
Serum
Plasma Cells
1 Citation (Scopus)

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

Hwa, Y. L., Gertz, M., Kumar, S. K., Lacy, M., Buadi, F. K., Dingli, D. M., Kapoor, P., Zeldenrust, S. R., Leung, N., Hayman, S. R., Gonsalves, W., Kourelis, T., Warsame, R., Go, R. S., Muchtar, E., Hobbs, M. A., Fonder, A. L., Russell, S. J., Kyle, R. A., Rajkumar, S. V. & 1 others, Dispenzieri, A., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Amyloidosis
Stem Cells
Therapeutics
Transplants
Survival
2 Citations (Scopus)

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

Sidana, S., Tandon, N., Brady, P. A., Grogan, M., Gertz, M., Dispenzieri, A., Lin, G. D., Dingli, D. M., Buadi, F. K., Lacy, M., Kapoor, P., Gonsalves, W., Muchtar, E., Warsame, R., Kumar, S. K. & Kourelis, T., Jan 1 2019, In : Mayo Clinic Proceedings.

Research output: Contribution to journalArticle

Amyloidosis
Light
Atrial Fibrillation
Ventricular Tachycardia
Ambulatory Electrocardiography
1 Citation (Scopus)

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

Tschautscher, M. A., Jevremovic, D., Rajkumar, S. V., Dispenzieri, A., Lacy, M., Gertz, M., Buadi, F. K., Dingli, D. M., Hwa, Y. L., Fonder, A. L., Hobbs, M. A., Hayman, S. R., Zeldenrust, S. R., Lust, J. A., Russell, S. J., Leung, N., Kapoor, P., Go, R. S., Lin, Y., Gonsalves, W. & 4 others, Kourelis, T., Warsame, R., Kyle, R. A. & Kumar, S. K., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Residual Neoplasm
Multiple Myeloma
Survival
Plasma Cells
Therapeutics
2 Citations (Scopus)

Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method

Sidana, S., Jevremovic, D., Ketterling, R. P., Tandon, N., Dispenzieri, A., Gertz, M., Greipp, P. T., Baughn, L., Buadi, F. K., Lacy, M., Morice, W., Hanson, C., Timm, M., Dingli, D. M., Hayman, S. R., Gonsalves, W., Kapoor, P., Kyle, R. A., Leung, N., Go, R. S. & 3 others, Lust, J. A., Rajkumar, S. V. & Kumar, S. K., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Polyploidy
Plasma Cells
Flow Cytometry
Trisomy
Fluorescence In Situ Hybridization
2 Citations (Scopus)

Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma

Gopalakrishnan, S., D'Souza, A., Scott, E., Fraser, R., Davila, O., Shah, N., Gale, R. P., Kamble, R., Diaz, M. A., Lazarus, H. M., Savani, B. N., Hildebrandt, G. C., Solh, M., Freytes, C. O., Lee, C., Kyle, R. A., Usmani, S. Z., Ganguly, S., Assal, A., Berdeja, J. & 14 others, Kanate, A. S., Dhakal, B., Meehan, K., Kindwall-Keller, T., Saad, A., Locke, F., Seo, S., Nishihori, T., Gergis, U., Gasparetto, C., Mark, T., Nieto, Y., Kumar, S. K. & Hari, P., Jan 1 2019, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Autologous Transplantation
Multiple Myeloma
Recurrence
Survival
Cell Transplantation

Substratification of patients with newly diagnosed standard-risk multiple myeloma

Binder, M., Rajkumar, S. V., Ketterling, R. P., Dispenzieri, A., Lacy, M., Gertz, M., Buadi, F. K., Hayman, S. R., Hwa, Y. L., Zeldenrust, S. R., Lust, J. A., Russell, S. J., Leung, N., Kapoor, P., Go, R. S., Gonsalves, W., Kyle, R. A. & Kumar, S. K., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival
Confidence Intervals
Abnormal Karyotype
Lymphocyte Count

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

Muchtar, E., Dispenzieri, A., Jevremovic, D., Dingli, D., Buadi, F. K., Lacy, M. Q., Gonsalves, W., Warsame, R., Kourelis, T. V., Hayman, S. R., Kapoor, P., Leung, N., Russell, S., Lust, J. A., Lin, Y., Go, R. S., Zeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & 1 others, Gertz, M. A., Jan 1 2019, (Accepted/In press) In : Amyloid.

Research output: Contribution to journalArticle

Amyloidosis
Plasma Cells
Flow Cytometry
Survival
Disease-Free Survival
1 Citation (Scopus)

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

Muchtar, E., Gertz, M., Lacy, M., Go, R. S., Buadi, F. K., Dingli, D. M., Grogan, M., Abou Ezzeddine, O., Hayman, S. R., Kapoor, P., Leung, N., Fonder, A., Hobbs, M., Hwa, Y. L., Gonsalves, W., Warsame, R., Kourelis, T., Russell, S. J., Lust, J. A., Lin, Y. & 5 others, Zeldenrust, S., Kyle, R. A., Rajkumar, S. V., Kumar, S. K. & Dispenzieri, A., Jan 1 2019, In : British journal of haematology.

Research output: Contribution to journalArticle

Amyloidosis
Survivors
Survival
Therapeutics
Trisomy
1 Citation (Scopus)

The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma

Raab, M. S., Thomas, S. K., Ocio, E. M., Guenther, A., Goh, Y. T., Talpaz, M., Hohmann, N., Zhao, S., Xiang, F., Simon, C., Vanasse, K. G. & Kumar, S. K., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Phosphotransferases
Maximum Tolerated Dose
Moloney murine leukemia virus
Therapeutics
5 Citations (Scopus)

The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies

Harding, T., Baughn, L., Kumar, S. K. & Van Ness, B., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Precision Medicine
Multiple Myeloma
Drug Resistance
Technology
Biomarkers
Stem Cell Transplantation
Multiple Myeloma
Survival
Therapeutics
Disease Progression

The stepchild in myeloma treatments: Is allogeneic transplantation not so bad after all?

Müller, A. M. S., Kumar, S. K. & Bruno, B., Jan 31 2019, In : Haematologica. 104, 2, p. 222-225 4 p.

Research output: Contribution to journalArticle

Open Access
Homologous Transplantation
2018
7 Citations (Scopus)
Stem Cell Transplantation
Multiple Myeloma
Statistical Factor Analysis
Stem Cells
Transplants
3 Citations (Scopus)

ARNT/HIF-1β links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma

Wu, C., Yang, T., Liu, Y., Lu, Y., Yang, Y., Liu, X., Liu, X., Ye, L., Sun, Y., Wang, X., Li, Q., Yang, P., Yu, X., Gao, S., Kumar, S. K., Jin, F., Dai, Y. & Li, W., Aug 1 2018, In : Cancer Medicine. 7, 8, p. 3899-3911 13 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Drug Resistance
Transcriptome
Chromosome Aberrations
Small Interfering RNA
1 Citation (Scopus)

Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma

Painuly, U., Ramakrishnan, V., Kimlinger, T., Wellik, L., Haug, J., Gonsalves, W., Bi, L., Huang, Z., Rajkumar, S. V. & Kumar, S. K., Oct 1 2018, In : Oncotarget. 9, 77, p. 34582-34594 13 p.

Research output: Contribution to journalArticle

Aurora Kinases
Multiple Myeloma
Apoptosis
Aneuploidy
Cell Line
1 Citation (Scopus)

Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75

Sidiqi, M. H., Aljama, M. A., Muchtar, E., Buadi, F. K., Warsame, R., Lacy, M., Dispenzieri, A., Dingli, D. M., Leung, N., Gonsalves, W., Kapoor, P., Kourelis, T., Hogan, W., Kumar, S. K. & Gertz, M., Jan 1 2018, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Stem Cells
Transplants
Stem Cell Transplantation
10 Citations (Scopus)

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

Paludo, J., Abeykoon, J. P., Shreders, A., Ansell, S. M., Kumar, S. K., Ailawadhi, S., King, R., Koehler, A. B., Reeder, C. B., Buadi, F. K., Dispenzieri, A., Lacy, M., Dingli, D. M., Witzig, T. E., Go, R. S., Gonsalves, W., Kourelis, T., Warsame, R., Leung, N., Habermann, T. M. & 6 others, Hayman, S., Lin, Y., Kyle, R. A., Rajkumar, S. V., Gertz, M. & Kapoor, P., Apr 3 2018, (Accepted/In press) In : Annals of Hematology. p. 1-9 9 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cyclophosphamide
Dexamethasone
Disease-Free Survival
Bendamustine Hydrochloride
2 Citations (Scopus)

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

Sidiqi, M. H., Aljama, M. A., Bin Riaz, I., Dispenzieri, A., Muchtar, E., Buadi, F. K., Warsame, R., Lacy, M., Dingli, D. M., Leung, N., Gonsalves, W., Kapoor, P., Kourelis, T., Hogan, W., Rajkumar, S. V., Kumar, S. K. & Gertz, M., Nov 1 2018, In : Blood Cancer Journal. 8, 11, 106.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Stem Cells
Transplants
Chromosome Aberrations
3 Citations (Scopus)

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG Research Project

Usmani, S. Z., Hoering, A., Cavo, M., Miguel, J. S., Goldschimdt, H., Hajek, R., Turesson, I., Lahuerta, J. J., Attal, M., Barlogie, B., Lee, J. H., Kumar, S. K., Lenhoff, S., Morgan, G., Rajkumar, S. V., Durie, B. G. M. & Moreau, P., Nov 23 2018, In : Blood Cancer Journal. 8, 12, 1 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Transplants
Survival
Research
Disease-Free Survival
21 Citations (Scopus)

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains

Sidana, S., Tandon, N., Dispenzieri, A., Gertz, M., Buadi, F. K., Lacy, M., Dingli, D. M., Fonder, A. L., Hayman, S. R., Hobbs, M. A., Gonsalves, W., Hwa, Y. L., Kapoor, P., Kyle, R. A., Leung, N., Go, R. S., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Rajkumar, S. V. & 1 others, Kumar, S. K., Mar 1 2018, In : Leukemia. 32, 3, p. 729-735 7 p.

Research output: Contribution to journalArticle

Amyloidosis
Light
Serum
Survival
Stem Cell Transplantation